MIT Technology Review

@techreview ↗

Deleted No

Hibernated Yes

Last Checked Aug. 22, 2022

Created

Mon Nov 29 21:37:06 +0000 2021

Likes

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

MIT Technology Review @techreview

If that’s the case, then vaccine manufacturers will have to move quickly to come up with new versions. Luckily, with mRNA technology it is relatively easy to reformulate a vaccine. https://t.co/y6w5EZVIDm — PolitiTweet.org

Posted Nov. 29, 2021 Hibernated

Preceded By

MIT Technology Review @techreview

We don’t have firm answers to any of these questions yet—although it seems likely, given the mutations, that it will affect the effectiveness of vaccines to some degree. — PolitiTweet.org

Posted Nov. 29, 2021 Hibernated

Followed By

MIT Technology Review @techreview

.@Moderna’s chief medical officer, Paul Burton, told the BBC on Sunday that his firm could have a new booster—one tweaked to handle omicron—ready to roll out as soon as early next year. https://t.co/oUjILda1V2 — PolitiTweet.org

"If we have to make a brand new vaccine, that's going to be early 2022" in terms of when it's available, says Paul… https://t.co/P88iOI86jD

Posted Nov. 29, 2021 Hibernated